Billionaire Paul Tudor Jones: Plans to Hold Cryptocurrency, Gold, and Nasdaq Tech Stocks by Year-End
ChainCatcher News, according to Golden Ten Data, billionaire hedge fund manager Paul Tudor Jones believes that market conditions are now in place for a strong rally in U.S. stocks, which will be followed by the peak of the bull market.
Jones stated: "My guess is that I think all the factors for a 'big bang' rally are already in place." He said, "History is always amazingly similar, so I think some version of this scenario will happen again. If there is any difference, it is that now is potentially even more explosive than 1999."
He believes that the bull market still has room to rise before entering its final stage. He said: "We need a speculative frenzy to push these prices higher. This requires more retail buying and greater participation from various long-short hedge funds and real money investors."
He stated that in order to take advantage of the rally driven by this 'fear of missing out' (FOMO) sentiment, he plans to hold a portfolio of gold, cryptocurrencies, and Nasdaq tech stocks from now until the end of this year.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
Crypto prices
More
